Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Angioedema due to fixed dose combination of telmisartan plus ramipril

    Vishal R. Tandon1★, Annil Mahajan2, Vijay Khajuria1, Zahid H. Gillani1★ Corresponding author

    1. 1Department of Pharmacology and Therapeutic, College, Jammu, Jammu and Kashmir, India Case Report.
    2. 2Department of General Medicine, Government Medical College, Jammu, Jammu and Kashmir, India Case Report.

    CORRESPONDENCE

    Vishal R. Tandon

    Department of Pharmacology and Therapeutic, College, Jammu, Jammu and Kashmir, India Case Report.

    Received: 03-08-2013; Revised: 20-11-2013; Accepted: 16-01-2014.

    Volume 5, Issue 3 · pp. 214–216 · PUBLISHED 2014 · DOI: 10.4103/0976-500X.136113

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    The risk for angioedema has been suggested lower with angiotensin receptor blockers (ARBs) than with angiotensin‑converting enzyme inhibitors (ACEIs) or aliskiren. Many isolated reports do exist, reporting angioedema with ARBs such as olmesartan, valsartan, losartan and telmisartan. To the best of our knowledge this is the first case report of telmisartan plus ramipril fixed dose combination leading to angioedema from India questioning the rationality of ARBs plus ACEIs combination in the treatment of hypertension.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Tandon, V. R., Mahajan, A., Khajuria, V., & Gillani, Z. H. (2014). Angioedema due to fixed dose combination of telmisartan plus ramipril. Journal of Pharmacology and Pharmacotherapeutics, 5(3), 214–216. https://doi.org/10.4103/0976-500X.136113